In quiet debut, Alzheimer’s drug finds questions, skepticism
The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Read moreThe first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Read moreSYDNEY (Reuters) – Sydney’s COVID-19 cases fell to the lowest in two months on Tuesday as authorities rolled out support
Read moreA new study from the lab of University of Kentucky Markey Cancer Director Mark Evers, M.D., demonstrates the critical role
Read moreAmy Dowden opens up about her battle with Crohn's disease We use your sign-up to provide content in ways you’ve
Read moreROME (Reuters) – Italy’s attempt to boost vaccinations by making a contested health pass necessary to go to work is
Read moreA first-line thrombectomy approach that combines contact aspiration and stent retrieval techniques does not significantly improve the reperfusion rate compared
Read moreJapanese researchers have successfully produced potent neutralizing monoclonal antibodies from a patient who recovered rapidly from a severe case of
Read moreA specific wavelength of ultraviolet (UV) light is not only extremely effective at killing the virus which causes COVID-19, but
Read moreYou know when you attend a baby shower (on Zoom or otherwise) and find yourself thinking, Holy crap, this is
Read moreThe study, which appears in the Oct. 4, 2021, issue of Nature Medicine, represents a landmark success in the years-long
Read more